Ilja Oomen, MD

PhD student, MD
Amsterdam UMC location University of Amsterdam, Department of Pediatric Hematology, Meibergdreef 9, Amsterdam, The Netherlands

Ilja Oomen, MD, PhD candidate at the Deparment of Pediatric Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands, under supervision of Prof. Karin Fijnvandraat, MD, PhD, Prof. Jan Voorberg, PhD, and Samantha Gouw, MD, PhD.

Her current research focusses on anti-FVIII and FIX antibodies and immune tolerance induction (ITI) therapy in patients with hemophilia A. She coordinates an international ITI Steering Group with investigators from Europe, Brazil and Canada. She aims to develop a prediction model based on predictors for the outcome of immune tolerance induction, to tailor therapies according to each patient’s individual chance of success. Additionally, she investigates the immunological mechanism underlying immune tolerance induction, with a cross-interaction of toll-like receptors and Fc gamma receptors with FVIII-immune complexes.

Presentation(s):

• OC 47.2 - Prevalence and characteristics of non-neutralizing FVIII-specific antibodies in persons with hemophilia A – preliminary results

  Monday, July 11, 2022
  3:00 PM – 3:15 PM

• PB1146 - Determinants of successful immune tolerance induction in persons with hemophilia A – systematic review and meta-analysis

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM